Functional role of Egr-1 mediating VEGF-induced tissue factor expression in the retinal capillary endothelium

Graefes Arch Clin Exp Ophthalmol. 2002 Dec;240(12):1003-10. doi: 10.1007/s00417-002-0576-6. Epub 2002 Nov 6.

Abstract

Purpose: To investigate the causal relationship between VEGF and tissue factor (TF) expression, and its intracellular signaling in the retinal capillary endothelium both in vitro and in vivo.

Methods: TF mRNA and protein expression in cultured bovine retinal capillary endothelial cells (BRECs) were detected by RT-PCR and western blotting. The expression and subcellular localization of Egr-1 were analyzed by immunocytochemistry and western blotting. Involvement of p44/p42 MAPK pathway in this signaling was assessed using PD98059. Electrophoretic mobility shift assay (EMSA) was performed using human TF Egr-1/Sp-1 overlapping promoter region (-85 to -70). Decoy oligonucleotide was transfected into BRECs to clarify the critical transcription factor mediating VEGF-induced TF gene expression. To evaluate the importance of GC rich region in VEGF-induced TF protein expression in rat retinas, Mithramycin was intraperitoneally administered.

Results: VEGF stimulated TF mRNA and protein expression in cultured BRECs, reaching maximal effect after 4 h and 10 h, respectively. VEGF activated transcription factor Egr-1 within 60 min. Inactivation of Egr-1 by PD98059 resulted in the prohibition of VEGF-induced TF gene expression. EMSA revealed the increment of Egr-1 binding with TF promoter region by displacing Sp1 after treatment with VEGF. Transfection of the Egr-1/Sp-1 overlapping decoy into BRECs inhibited VEGF-dependent TF gene expression. Mithramycin almost completely suppressed VEGF-induced TF protein expression in retinal capillary system in vivo (80%, p<0.01).

Conclusion: Transcription factor Egr-1, which lies downstream of p44/p42 MAPK, critically mediates VEGF-dependent TF expression in the retinal capillary endothelium.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Blotting, Western
  • Capillaries
  • Cattle
  • Cells, Cultured
  • DNA-Binding Proteins / antagonists & inhibitors
  • DNA-Binding Proteins / physiology*
  • Early Growth Response Protein 1
  • Electrophoretic Mobility Shift Assay
  • Endothelial Growth Factors / antagonists & inhibitors
  • Endothelial Growth Factors / pharmacology*
  • Endothelium, Vascular / cytology
  • Endothelium, Vascular / drug effects*
  • Endothelium, Vascular / metabolism
  • Flavonoids / pharmacology
  • Immediate-Early Proteins*
  • Immunohistochemistry
  • Intercellular Signaling Peptides and Proteins / pharmacology*
  • Lymphokines / antagonists & inhibitors
  • Lymphokines / pharmacology*
  • Male
  • Mitogen-Activated Protein Kinase 1 / metabolism
  • Mitogen-Activated Protein Kinase 3
  • Mitogen-Activated Protein Kinases / metabolism
  • Plicamycin / pharmacology
  • RNA, Messenger / metabolism
  • Rats
  • Rats, Inbred BN
  • Retinal Vessels / cytology*
  • Retinal Vessels / metabolism
  • Reverse Transcriptase Polymerase Chain Reaction
  • Signal Transduction
  • Thromboplastin / biosynthesis*
  • Thromboplastin / genetics
  • Transcription Factors / antagonists & inhibitors
  • Transcription Factors / physiology*
  • Up-Regulation
  • Vascular Endothelial Growth Factor A
  • Vascular Endothelial Growth Factors

Substances

  • DNA-Binding Proteins
  • Early Growth Response Protein 1
  • Egr1 protein, rat
  • Endothelial Growth Factors
  • Flavonoids
  • Immediate-Early Proteins
  • Intercellular Signaling Peptides and Proteins
  • Lymphokines
  • RNA, Messenger
  • Transcription Factors
  • Vascular Endothelial Growth Factor A
  • Vascular Endothelial Growth Factors
  • Thromboplastin
  • Mitogen-Activated Protein Kinase 1
  • Mitogen-Activated Protein Kinase 3
  • Mitogen-Activated Protein Kinases
  • Plicamycin
  • 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one